UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes

Diabetes technology & therapeutics, 2019-02, Vol.21 (2), p.81-85

2019

Volltextzugriff (PDF)

Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes

Diabetes care, 2018-11, Vol.41 (11), p.2370-2376

2018

Volltextzugriff (PDF)

Inequity in Adoption of Advanced Diabetes Technologies Among Medicare Fee-for-service Beneficiaries

The journal of clinical endocrinology and metabolism, 2022-04, Vol.107 (5), p.e2177-e2185

2022

Volltextzugriff (PDF)

Racial/Ethnic Inequities in Use of Diabetes Technologies Among Medicare Advantage Beneficiaries With Type 1 Diabetes

The journal of clinical endocrinology and metabolism, 2023-07, Vol.108 (7), p.e388-e395

2023

Volltextzugriff (PDF)

Role of Continuous Glucose Monitoring for Type 2 in Diabetes Management and Research

Journal of diabetes and its complications, 2017-01, Vol.31 (1), p.280-287

2017

Volltextzugriff (PDF)

The Myth of MARD ( M ean A bsolute R elative D ifference): Limitations of MARD in the Clinical Assessment of Continuous Glucose Monitoring Data

Diabetes technology & therapeutics, 2024-03, Vol.26 (S3), p.38-44

2024

Volltextzugriff (PDF)

1264-P: Racial and Ethnic Inequities in Use of Diabetes Technology among Medicare Advantage Beneficiaries with Type 1 Diabetes

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Going beyond HbA1c to understand the benefits of advanced diabetes therapies

Journal of diabetes, 2019-01, Vol.11 (1), p.23-31

Vigersky, Robert A.

2019

Volltextzugriff (PDF)

Time in Range Is Associated with Carotid Intima-Media Thickness in Type 2 Diabetes

Diabetes technology & therapeutics, 2020-02, Vol.22 (2), p.72-78

2020

Volltextzugriff (PDF)

The Benefits, Limitations, and Cost-Effectiveness of Advanced Technologies in the Management of Patients With Diabetes Mellitus

Journal of Diabetes Science and Technology, 2015-03, Vol.9 (2), p.320-330

Vigersky, Robert A.

2015

Volltextzugriff (PDF)

Glycemic Outcomes During Real-World Hybrid Closed-Loop System Use by Individuals With Type 1 Diabetes in the United States

Journal of diabetes science and technology, 2023-07, Vol.17 (4), p.951-958

2023

Volltextzugriff (PDF)

A Review of Precision Insulin Management With Smart Insulin Pens: Opening Up the Digital Door to People on Insulin Injection Therapy

Journal of diabetes science and technology, 2023-03, Vol.17 (2), p.283-289

2023

Volltextzugriff (PDF)

The Clinical Endocrinology Workforce: Current Status and Future Projections of Supply and Demand

The journal of clinical endocrinology and metabolism, 2014-09, Vol.99 (9), p.3112-3121

2014

Volltextzugriff (PDF)

Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes

Diabetes care, 2021-04, Vol.44 (4), p.969-975

2021

Volltextzugriff (PDF)

Continuous Glucose Monitoring in Patients With Type 2 Diabetes Receiving Insulin Injections

Annals of internal medicine, 2018-04, Vol.168 (7), p.528

Vigersky, Robert A.

2018

Volltextzugriff (PDF)

Shining the Spotlight on Multiple Daily Insulin Therapy: Real-World Evidence of the InPen Smart Insulin Pen

Diabetes technology & therapeutics, 2024-01, Vol.26 (1), p.33-39

2024

Volltextzugriff (PDF)

Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society

Diabetes care, 2013-05, Vol.36 (5), p.1384-1395

2013

Volltextzugriff (PDF)

The Effectiveness of Virtual Training on the MiniMed™ 670G System in People with Type 1 Diabetes During the COVID-19 Pandemic

Diabetes technology & therapeutics, 2021-02, Vol.23 (2), p.104-109

2021

Volltextzugriff (PDF)

Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels

Diabetes technology & therapeutics, 2020-02, Vol.22 (2), p.103-111

2020

Volltextzugriff (PDF)

111-LB: Smart Insulin Pen Correction Doses Delivered within Three Hours of a Previous Insulin Dose Improve Glycemia

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

TIR generated by continuous glucose monitoring is associated with peripheral nerve function in type 2 diabetes

Diabetes research and clinical practice, 2020-08, Vol.166, p.108289-108289, Article 108289

2020

Volltextzugriff (PDF)

Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes

Diabetes technology & therapeutics, 2022-03, Vol.24 (3), p.178-189

2022

Volltextzugriff (PDF)

The Comprehensive Glucose Pentagon: A Glucose-Centric Composite Metric for Assessing Glycemic Control in Persons With Diabetes

Journal of diabetes science and technology, 2018-01, Vol.12 (1), p.114-123

2018

Volltextzugriff (PDF)

Association between glycaemia risk index (GRI) and diabetic retinopathy in type 2 diabetes: A cohort study

Diabetes, obesity & metabolism, 2023-09, Vol.25 (9), p.2457-2463

2023

Volltextzugriff (PDF)

Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes

Diabetes care, 2012-01, Vol.35 (1), p.32-38

2012

Volltextzugriff (PDF)

1 – 25 von 243

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(222)
Mit Volltextzugriff
(189)

Publikationsform

Sprache

Englisch
(243)

Erscheinungsjahr

n.n

Thema

Science & Technology
(122)
Life Sciences & Biomedicine
(120)
Humans
(111)
Endocrinology & Metabolism
(79)
Diabetes
(66)
Male
(52)
Female
(43)
Adult
(42)
Insulin
(39)
Middle Aged
(35)
Glucose
(33)
Aged
(28)
Hypoglycemic Agents - Therapeutic Use
(27)
Blood Glucose - Analysis
(26)
Insulin - Therapeutic Use
(26)
Hypoglycemia
(25)
Biological And Medical Sciences
(24)
Diabetes Mellitus
(24)
Glucose Monitoring
(24)
Diabetes Mellitus, Type 1 - Drug Therapy
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes

Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes

Inequity in Adoption of Advanced Diabetes Technologies Among Medicare Fee-for-service Beneficiaries

Racial/Ethnic Inequities in Use of Diabetes Technologies Among Medicare Advantage Beneficiaries With Type 1 Diabetes

Role of Continuous Glucose Monitoring for Type 2 in Diabetes Management and Research

The Myth of MARD ( M ean A bsolute R elative D ifference): Limitations of MARD in the Clinical Assessment of Continuous Glucose Monitoring Data

1264-P: Racial and Ethnic Inequities in Use of Diabetes Technology among Medicare Advantage Beneficiaries with Type 1 Diabetes

Going beyond HbA1c to understand the benefits of advanced diabetes therapies

Time in Range Is Associated with Carotid Intima-Media Thickness in Type 2 Diabetes

The Benefits, Limitations, and Cost-Effectiveness of Advanced Technologies in the Management of Patients With Diabetes Mellitus

Glycemic Outcomes During Real-World Hybrid Closed-Loop System Use by Individuals With Type 1 Diabetes in the United States

A Review of Precision Insulin Management With Smart Insulin Pens: Opening Up the Digital Door to People on Insulin Injection Therapy

The Clinical Endocrinology Workforce: Current Status and Future Projections of Supply and Demand

Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes

Continuous Glucose Monitoring in Patients With Type 2 Diabetes Receiving Insulin Injections

Shining the Spotlight on Multiple Daily Insulin Therapy: Real-World Evidence of the InPen Smart Insulin Pen

Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society

The Effectiveness of Virtual Training on the MiniMed™ 670G System in People with Type 1 Diabetes During the COVID-19 Pandemic

Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels

111-LB: Smart Insulin Pen Correction Doses Delivered within Three Hours of a Previous Insulin Dose Improve Glycemia

TIR generated by continuous glucose monitoring is associated with peripheral nerve function in type 2 diabetes

Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes

The Comprehensive Glucose Pentagon: A Glucose-Centric Composite Metric for Assessing Glycemic Control in Persons With Diabetes

Association between glycaemia risk index (GRI) and diabetic retinopathy in type 2 diabetes: A cohort study

Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes

Suchergebnisse filtern